AR062835A1 - A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION - Google Patents

A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION

Info

Publication number
AR062835A1
AR062835A1 ARP070103846A ARP070103846A AR062835A1 AR 062835 A1 AR062835 A1 AR 062835A1 AR P070103846 A ARP070103846 A AR P070103846A AR P070103846 A ARP070103846 A AR P070103846A AR 062835 A1 AR062835 A1 AR 062835A1
Authority
AR
Argentina
Prior art keywords
preparation
cicatrization
application
stimulating composition
selective stimulating
Prior art date
Application number
ARP070103846A
Other languages
Spanish (es)
Inventor
Andrea Giuliani
Ana Cruces
Walter Montagni
Rosalia Mlynarz
Patricia Duarte
Original Assignee
Walter Montagni
Rosalia Mlynarz
Ana Cruces
Andrea Giuliani
Patricia Duarte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter Montagni, Rosalia Mlynarz, Ana Cruces, Andrea Giuliani, Patricia Duarte filed Critical Walter Montagni
Priority to ARP070103846A priority Critical patent/AR062835A1/en
Priority to PCT/IB2008/002346 priority patent/WO2009027823A2/en
Publication of AR062835A1 publication Critical patent/AR062835A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Abstract

Composicion química compuesta por gentamicina, metronidazol, papaina, bálsamo del Peru, lanolina y vaselina solida, para el tratamiento de heridas y otras lesiones cutáneas en medicina humana, veterinaria y tratamientos odontologicos. Preparacion y uso.Chemical composition composed of gentamicin, metronidazole, papain, balsam of Peru, lanolin and solid petrolatum, for the treatment of wounds and other skin lesions in human medicine, veterinary medicine and dental treatments. Preparation and use.

ARP070103846A 2007-08-29 2007-08-29 A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION AR062835A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP070103846A AR062835A1 (en) 2007-08-29 2007-08-29 A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION
PCT/IB2008/002346 WO2009027823A2 (en) 2007-08-29 2008-08-29 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP070103846A AR062835A1 (en) 2007-08-29 2007-08-29 A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION

Publications (1)

Publication Number Publication Date
AR062835A1 true AR062835A1 (en) 2008-12-10

Family

ID=40225122

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103846A AR062835A1 (en) 2007-08-29 2007-08-29 A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION

Country Status (2)

Country Link
AR (1) AR062835A1 (en)
WO (1) WO2009027823A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095702A1 (en) * 2011-01-13 2012-07-19 Medestea Internazionale S.P.A. A composition for the regeneration of atrophic tissues
CN102241712B (en) * 2011-05-23 2014-04-02 南阳普康药业有限公司 Decolorizing method for gentamicin sulfate production
CN104435345A (en) * 2014-11-11 2015-03-25 四川金堂海纳生物医药技术研究所 Orally taken medicine for treating pulpitis and preparation method thereof
BE1024364B9 (en) * 2016-06-29 2018-03-07 Holding Tolpoort Bvba COMPOSITION FOR TREATMENT OF PERNIOSIS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189650C (en) * 1978-05-30 1993-06-16 Ace Veterinary Products B V PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF WOUNDS.
WO2000038617A2 (en) * 1998-12-24 2000-07-06 Four Star Partners Compositions and methods of using the same
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
EP1948236B1 (en) * 2005-09-27 2021-03-03 Special Water Patents B.V. Methods and compositions for treatment of skin
CA2626208A1 (en) * 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
WO2007084127A1 (en) * 2006-01-20 2007-07-26 Verdon Peters Use of gluten for wound treatment as active healing ingredient

Also Published As

Publication number Publication date
WO2009027823A3 (en) 2009-04-23
WO2009027823A2 (en) 2009-03-05
WO2009027823A9 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
EA201100335A1 (en) PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-ASSOCIATED DISEASES
CL2016000530A1 (en) Treatment of osteoarthritis and pain (divisional sun. No. 2298-13).
CL2012002326A1 (en) Use of a combination of at least one chemotherapeutic agent and an effective amount of an anti-vegf antibody (vascular endothelial growth factor), because it serves to prepare a medicament useful in the treatment of ovarian cancer; and his kit to treat ovarian cancer without prior treatment in a human patient.
AR086051A1 (en) METHOD TO TREAT COLORRECTAL CANCER, COMPOSITION THAT INCLUDES AFLIBERCEPT, FOLINIC ACID, 5-FLUOROURACILO (5-FU) AND IRINOTECANO (FOLFIRI), ARTICLE MANUFACTURED, KIT
ECSP12011943A (en) MDPI2 ESPIRO-OXINDOL ANTAGONISTS
BRPI0923589A2 (en) use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin.
ES2530417T3 (en) Dressing device for use with a cannula or catheter
AR061171A1 (en) PROTEINS OF UNION TO THE GROWTH FACTOR OF HEPATOCITS (FCH)
CL2010001260A1 (en) Pharmaceutical composition comprising a salt of strontium and vitamin D and a cyclodextrin, where the mass ratio between the amount of vitamin D and the amount of cyclodextrin is between 1/40 and 1/800, useful for treating or preventing osteoporosis.
AR061170A1 (en) PROTEINS THAT JOIN THE HEPATOCITE GROWTH FACTOR (HGF)
AR057868A1 (en) METHODS IN WHICH USES 3- (4-AMINO-1-OXO-1,3-DIHIDRO-ISOINDOL-2-IL) -PIPERIDIN-2,6-DIONA FOR THE TREATMENT OF CERTAIN LEUKEMIA
ECSP109889A (en) THERAPEUTIC COMPOSITIONS AND USES OF THE SAME
WO2009075882A3 (en) Impaired wound healing compositions and treatments
CL2009001077A1 (en) Polymeric particulate carrier comprising a biological agent in aqueous phase in a hollow lumen; procedure to deliver a protein to the eye; pharmaceutical composition comprising said vehicle; and its use for prophylaxis and treating diseases or disorders of the eye.
ECSP066805A (en) SILINAN COMPOUNDS AS INHIBITORS OF CYSTEINE PROTEASA
UY30158A1 (en) USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR PAIN TREATMENT
AR072654A1 (en) BIOCIDE COMBINATION FOR USE IN AGRICULTURAL APPLICATIONS
CL2008002545A1 (en) Phenoxy-benzyl-carbamoyl derived compounds; pharmaceutical composition; process for preparing the pharmaceutical composition; and its use in the treatment of pain.
CL2012003266A1 (en) Tamarind seed polysaccharide for use in the treatment of microbial infections; pharmaceutical and / or antimicrobial dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide; method to treat and / or prevent a patient who has a microbial infection.
ECSP099807A (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND ITS USE IN THE FIELD OF THE BLOOD COAGULATION
AR062835A1 (en) A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION
CO2019003865A2 (en) Therapeutic protein
DOP2017000055A (en) ANAMORELINE BASED MEDICAL TREATMENTS
CO6761349A2 (en) Antimicrobial protein
DE602008003199D1 (en) GLUCOSEISOMERASE FOR THE TREATMENT OF FRUCTOSE INCOMPATIBILITY

Legal Events

Date Code Title Description
FC Refusal